Skip to main content

Table 1 Feasibility objectives and endpoints for the HATRIC trial

From: HATRIC: a study of Pelargonium sidoides root extract EPs®7630 (Kaloba®) for the treatment of acute cough due to lower respiratory tract infection in adults—study protocol for a double blind, placebo-controlled randomised feasibility trial

Feasibility objective

Endpoint used to evaluate

Eligibility: number of patients included and number excluded (+ reasons) from the trial

On site screening logs

Recruitment: ability to recruit patients into the intervention from those attending primary care

On site enrolment records—monthly rate/site adjusted for site list size

Randomisation: willingness to be randomised

Proportion of eligible patients recruited

Retention: across the duration of the intervention and return of a fully completed diary

Quantitative data from enrolment

Withdrawal rate from study

Completion of outcome measures

Intervention compliance

Diary data and returned medication

Patient preference for liquid/tablet formulation

Diary data

Returned medication

Recruitment data

Establish the frequency of collecting EQ5D questionnaire and identifying the key resources associated with the intervention and potential influence on service usage

Establish methods of data collection for the health economics analysis

Development of health economic protocol and collection of outcome data EQ-5D-5L questionnaire and case note review

Acceptability of the patient diaries, patients’ willingness to complete them, and the importance of telephone/text contact

Quantitative data collection—percentage of patients returning completed diaries

Success of delayed antibiotic strategy

Diary data on day antibiotics commenced

Need for stratification by antibiotic strategy in main study

Proportion allocated to immediate and delayed antibiotic strategy

To inform sample size for future trials

Rate of outcome measures in the control group

Quality of life measurements and resource use

Identify the key resource items to be collected and how often to collect EQ-5D-5L in the full trial